Oxford Performance Materials Opens New South Windsor Facility to Support 3D Printing of Aerospace Components
September 9, 2013
- New facility to support Mission Critical OXPEKK® aerospace production
Oxford Performance Materials (OPM) is pleased to announce the creation of a new manufacturing facility in South Windsor, CT. The facility is in close proximity to OPM’s current headquarters and manufacturing facility. This region of Connecticut, long known for its advanced subtractive manufacturing technologies, is now rapidly becoming a global leader in additive manufacturing. "It has always been our intention to pivot from biomedical 3D printing to Mission Critical aerospace and industrial structures," said Scott DeFelice, President and CEO of OPM. “This new facility will bring together world class technologies and capabilities in order to service the exacting demands of our customers in the fast evolving 3D printing marketplace."
July 29, 2013
– Contract award initiated by NAMII further enhances the firm’s position in mission-critical additive manufacturing
Oxford Performance Materials (OPM) is very pleased to announce that it has received a contract from Northrop Grumman Systems Corporation (NGSC) for the development of its OXPEKK® polymer for use in aerospace applications. OPM shall undertake the production of test specimens and prototype components that will allow for the establishment of a structural design database. Such a database is a necessary requirement for the design of aerospace and other critical structures.
April 8, 2013
– Biomet Microfixation signs agreement for exclusive distribution of OPM’s OsteoFab™ cranial implants
Oxford Performance Materials (OPM) and Biomet Microfixation (Biomet) have entered into an exclusive distribution agreement for OPM’s OsteoFab™ Patient Specific Cranial Device (OPSCD). Under the terms of the agreement, Biomet will have exclusive global distribution rights to the OPSCD and OsteoFab™ implants for craniomaxillofacial (CMF).
OsteoFab™ Patient Specific Cranial Device Receives 510(k) Approval - OsteoFab™ Implants Ready for US Market and Beyond
February 18, 2013
Oxford Performance Materials (OPM) is pleased to announce it has received FDA 510(k) clearance for the OsteoFab™ Patient Specific Cranial Device (OPSCD). “OsteoFab” is OPM’s brand for Additively Manufactured medical and implant parts produced from PEKK polymer. With OPM’s Additive Manufacturing process (also called “3D Printing”), implants are “grown” layer by layer directly from a digital CAD file without the aid of tooling and with few practical limits on what can be produced. As such, the OsteoFab™ technology is ideal for one-of implants specifically shaped to each patient’s anatomy. One very desirable use of patient specific implants and the indication for the OPSCD is cranial implants to replace bony voids in the skull due to trauma or disease. FDA clearance of this device marks the first approval for an additively manufactured polymer implant.
Oxford Performance Materials to Participate in the National Additive Manufacturing Innovation Institute (NAMII)
August 22, 2012
Oxford Performance Materials (South Windsor, CT) has been selected as part of a team to participate in the National Additive Manufacturing Innovation Institute (NAMII). NAMII is the pilot institute for the National Network for Manufacturing Innovation (NNMI), the initiative announced by President Obama in March 2012. OPM will work as part of a larger team of universities, companies, and organizations led by the National Center for DeFense Manufacturing and Machining (NCDMM). A collaborative inter-agency team determined that Additive Manufacturing, specifically, would garnish the most benefit for the nation’s defense, energy, space and commercial sectors.
OPM Acquires Optical Inspection Technology Rights from the Connecticut Center for Advanced Technology
July 30, 2012
Oxford Performance Materials (OPM) has acquired the rights to modify and advance the Structured Light Scanning (SLS) system developed by Connecticut Center for Advanced Technology, Inc. (CCAT). The technology was designed by CCAT under a U.S. Air Force research contract to produce 100% optical measurement of highly complex, light-weight, efficient structures.
OPM is at the forefront of creating such complex structures via additive manufacturing in both biomedical and industrial markets. The opportunity to enhance a technology and further customize it to the needs of a rapidly emerging technology like additive manufacturing will allow for greater adoption of Structured Light Scanning and will propel the wide-spread use of additive manufacturing.
December 9, 2011
by Biloine W. Young in the Orthopedics This Week
OsteoFab, a division of Oxford Performance Materials (OPM) of South Windsor, Connecticut has manufactured and shipped its first patient-specific implant. According to OPM President Scott DeFelice, the custom-designed implant is made by a selective laser sintering machine from a polymer called polyetherketoneketone or PEKK.
November 29, 2011
Oxford Performance Materials is pleased to announce that an innovative spinal device made from OXPEKK®-IG has recently received regulatory approvals in two South American countries. Following great success in Europe, the FILL-SQUALE™ cervical cage has been approved for long-term implantation by ANMAT and DIGEMID, the regulatory authorities in Argentina and Peru, respectively.
July 5, 2011
OPM is very pleased to announce it has secured funding for the purchase of an EOSINT P 800 SLS machine for the production of the firm's OsteoFab™ medical implants. The funding was provided by the Connecticut Innovations, Inc.'s BioScience Facilities Fund.
June 21, 2011
Oxford Performance Materials is pleased to announce the recent opening of a new European office in the Netherlands. The firm has long had a strong customer base in Europe, most notably in France and Germany, a base that continues to grow as OPM introduces new technologies to their OXPEKK® product line.
June 6, 2011
The founders of Oxford Performance Materials, Inc. (OPM) have acquired the PEKK medical business from Arkema, Inc. From the founding of OPM in 2000 the firm has nurtured both industrial and medical business activities. Since the acquisition of Arkema in 2009 both business units have grown rapidly.
September 8, 2010
-Brazilian Market Growth Anticipated for OXPEKK-IG, OPM’s branded PEKK
Oxford Performance Materials (OPM) is pleased to announce that a medical device produced with its OXPEKK®-IG polymer has received ANVISA clearance. ANVISA is the regulatory authority for the Brazilian market. The approved device is produced by Sintea Plustek and is a long-term spinal implant. This regulatory clearance now establishes a path forward for OPM to sell its products in the highly dynamic Brazilian market.
July 15, 2010
-US Market Focus Accelerating for OXPEKK®-IG, OPM's branded PEKK
Oxford Performance Materials (OPM) is pleased to announce that a long-term implantable medical device manufactured with its OXPEKK®-IG polymer has received 510(k) Clearance by the United States Food and Drug Administration (FDA). The device is produced by Kent Medical Devices (KMD) from OPM’s radio-opaque OXPEKK®-IG polymer containing barium sulfate. This regulatory clearance now establishes a path forward for OPM to sell its products in the highly desirable US market.
July 8, 2010
-KFDA Acceptance of OXPEKK-IG Implantable Polymer
Oxford Performance Materials (OPM) is very pleased to announce that the firm’s OXPEKK-IG long-term implantable polymer has been accepted by the Korean Food and Drug Administration (KFDA). The KFDA approved the Viking interspinous spinal device made by OPM’s customer Sintea Plustek.